iCARE4CVD 3rd annual meeting – 2,5 years of progress!
On 26–27 August, 75 consortium members from 40 partner organisations gathered in Munich for our fourth Annual Consortium Meeting, hosted by Amgen. Over two days, we stepped away from our usual online meetings, labs, hospitals and offices to share what we have achieved over the past year, exchange ideas and focus on what comes next!
Can AI make heart failure evidence reviews faster and more reliable? New iCARE4CVD research puts it to the test
Screening thousands of research papers is one of the most time-consuming steps in evidence synthesis. A new study from the iCARE4CVD consortium asks whether large language models can do it reliably — and at scale.
Prediction or speculation: heart failure models for diabetes – An Editorial comment from iCARE4CVD
Can we predict heart failure in people with diabetes, or are we merely speculating? That is the question explored in a recent iCARE4CVD editorial, which discusses a large meta-analysis evaluating more than 50 prediction models designed to identify individuals with type 2 diabetes who are at risk of developing heart failure or being hospitalised because of it.
